Press Releases

12/21/2009
Labopharm completes distribution and supply agreement with MSD for Tradorec XL (R) (once-daily tramadol) in the United Kingdom

12/21/2009
Labopharm announces intention to draw down $1 million on standby equity distribution agreement

12/17/2009
Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe

11/25/2009
Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement

11/20/2009
Labopharm to present at Dundee Emerging Growth Summit

11/10/2009
Labopharm's novel trazodone formulation subject of publication in peer-reviewed medical journal

11/6/2009
Labopharm Reports Results for Third Quarter Fiscal 2009

10/29/2009
Labopharm to host conference call Friday, November 6, 2009 at 10:00 a.m. (ET)

10/8/2009
Labopharm completes distribution and supply agreement with Grunenthal for twice-daily tramadol-acetaminophen for a number of European countries

10/7/2009
Labopharm announces that its trazodone API supplier has resolved outstanding manufacturing issues with the FDA

9/30/2009
Labopharm receives notice of ANDA submission with paragraph IV certification for generic of Ryzolt(TM)

9/9/2009
Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings

8/25/2009
Labopharm's response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission

8/17/2009
Labopharm comments on judgment in Purdue patent litigation

8/11/2009
Labopharm submits response to FDA for novel antidepressant

8/7/2009
Labopharm Reports Results for Second Quarter Fiscal 2009

8/5/2009
Labopharm files New Drug Submission with Health Canada for novel antidepressant

7/30/2009
Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference

7/27/2009
Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)

7/20/2009
Labopharm receives complete response letter from the U.S. FDA for novel antidepressant

6/25/2009
Labopharm amends debt facility agreement with Hercules

5/19/2009
Results of phase III study on Labopharm's novel antidepressant published in Psychiatry (Edgemont) Journal

5/7/2009
Labopharm Reports Results for First Quarter Fiscal 2009

4/23/2009
Labopharm announces details for first quarter results conference call and annual meeting

4/2/2009
Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation

3/10/2009
Labopharm to present at Cowen 29th Annual Health Care Conference

2/26/2009
Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008

2/12/2009
Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET)

1/5/2009
Labopharm to host conference call to discuss FDA approval of once-daily RYZOLT(TM) on Tuesday, January 6, 2009 at 8:30 a.m. (ET)